glp-1 advertising Is Marketing Attacking Our Mental Health? GLP-1 Advertising Boom - News

Individual ingredients have published research, but no OTC finished product has been shown in a peer-reviewed trial to replicate the 7-24% body weight loss that prescription GLP-1 receptor agonists produce

doi: 10.2337/dc12-0922 66 NisarOPervezHMandaliaBWaqasMSraHK

Behind Novo and Lilly: The Emerging GLP1 Challengers While Novo and Lilly lead the global GLP1 race, new challengers across the U.S., India, and China are rapidly gaining ground

3-6

And we can think of this program as a temporary bridge to kind of open up and expand access to GLP-1s for obesity in Medicare patients while CMS evaluates what longer-term coverage will look like